Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andras Perl

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Genome Informatics. International Conference on Genome Informatics|May 16, 2007
Computational methods for functional site identification suggest a substrate access channel in transaldolaseMichael Silberstein, Melissa R Landon, Yaoyu E Wang, et al.
Research Square|June 30, 2025
RAB4A DRIVES PROINFLAMMATORY CD4<sup>+</sup> T CELL SIGNALING VIA CD38-DEPENDENT NAD<sup>+</sup> METABOLISMJoy S Park, Daniel Krakko, Jessica Nolan, et al.
Lancet (London, England)|September 8, 2018
Sirolimus for systemic lupus erythematosus - Authors' replyAndras Perl, Zhi-Wei Lai, Ryan Kelly, et al.
Frontiers in Immunology|July 24, 2025
Spectral cytometry of rheumatoid arthritis patients implicates myeloid dendritic cells and granular HLA-DR+CD15+CD16+ cells in pro-inflammatory antigen presentationChristian Geier, Haani Qudsi, Estelle Khairallah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosusPeter Gergely, Brian Niland, Nick Gonchoroff, et al.
The Journal of Rheumatology|December 31, 2009
Induction of systemic lupus erythematosus with tumor necrosis factor blockersEkaterina Soforo, Manfred Baumgartner, Lisa Francis, et al.
Current Opinion in Rheumatology|June 25, 2009
T-cell and B-cell signaling biomarkers and treatment targets in lupusAndras Perl, David R Fernandez, Tiffany Telarico, et al.
Clinical Rheumatology|July 14, 2007
Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatinLisa Francis, Eduardo Bonilla, Ekaterina Soforo, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 26, 2008
Bifunctional, chemically patterned flat stamps for microcontact printing of polar inksXuexin Duan, Veera B Sadhu, Andras Perl, et al.
Annals of Translational Medicine|August 15, 2020
Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literatureJihad Ben Gabr, Eric Liu, Sundus Mian, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Genome Informatics. International Conference on Genome Informatics|May 16, 2007
Computational methods for functional site identification suggest a substrate access channel in transaldolaseMichael Silberstein, Melissa R Landon, Yaoyu E Wang, et al.
Research Square|June 30, 2025
RAB4A DRIVES PROINFLAMMATORY CD4<sup>+</sup> T CELL SIGNALING VIA CD38-DEPENDENT NAD<sup>+</sup> METABOLISMJoy S Park, Daniel Krakko, Jessica Nolan, et al.
Lancet (London, England)|September 8, 2018
Sirolimus for systemic lupus erythematosus - Authors' replyAndras Perl, Zhi-Wei Lai, Ryan Kelly, et al.
Frontiers in Immunology|July 24, 2025
Spectral cytometry of rheumatoid arthritis patients implicates myeloid dendritic cells and granular HLA-DR+CD15+CD16+ cells in pro-inflammatory antigen presentationChristian Geier, Haani Qudsi, Estelle Khairallah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosusPeter Gergely, Brian Niland, Nick Gonchoroff, et al.
The Journal of Rheumatology|December 31, 2009
Induction of systemic lupus erythematosus with tumor necrosis factor blockersEkaterina Soforo, Manfred Baumgartner, Lisa Francis, et al.
Current Opinion in Rheumatology|June 25, 2009
T-cell and B-cell signaling biomarkers and treatment targets in lupusAndras Perl, David R Fernandez, Tiffany Telarico, et al.
Clinical Rheumatology|July 14, 2007
Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatinLisa Francis, Eduardo Bonilla, Ekaterina Soforo, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 26, 2008
Bifunctional, chemically patterned flat stamps for microcontact printing of polar inksXuexin Duan, Veera B Sadhu, Andras Perl, et al.
Annals of Translational Medicine|August 15, 2020
Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literatureJihad Ben Gabr, Eric Liu, Sundus Mian, et al.
Pageof 15